Check out the companies making headlines in after-hours trading: Domino's Pizza , Ulta Beauty — Shares surged about 8% after Berkshire Hathaway announced a new stake in the pizza chain in a regulatory filing. The Warren Buffett-led firm bought more than 1.2 million shares, making the stake worth around...
Disney is back. After several quarters of cutting costs and revamping its streaming business, CEO Robert Iger's turnaround plans is paying off: On Thursday, the entertainment giant reported strong quarterly earnings and a robust outlook for the coming year. Revenue in the fiscal fourth quarter totaled $22.57 billion, topping...
Check out the companies making headlines in midday trading: Disney — The media stock popped 7% on stronger-than-expected earnings and guidance, aided by growth in its streaming business. The company said it expects high-single-digit adjusted earnings growth in fiscal 2025. Capri , Tapestry — Both luxury apparel stocks rose...
Scene from the FX series Shogun.Source: Disney | FXDisney has done the math on separating its TV networks business, and it appears too messy to be done — at least for now.The company's chief financial officer, Hugh Johnston, said Thursday on CNBC's "Squawk Box" that the "cost is probably...
Baupost's Seth Klarman took a sizable stake in discount store Dollar General last quarter, while exiting Michael Kors-owner Capri before its megadeal to merge with Tapestry was blocked by regulators. The notable hedge fund investor built a $195 million stake in Dollar General, making it his eighth biggest holding...
Check out the companies making...
Disney is back. After several...
Gregg Greenberg spent 14 years as a journalist at TheStreet.com where he wrote the highly popular column "The 5 Dumbest Things on Wall Street This Week". His work has appeared in magazines ranging from Glamour to ESPN the Magazine, and on humor sites such as Points in Case.
For the past several decades, platforms for advisors have differentiated themselves by the quality of their technology. The focus on tech was an evolution for the platforms, which originally distinguished themselves by the quality of their proprietary products, the primary way brokerage firms and insurance companies attracted advisors in...
Check out the companies making headlines in premarket trading. Hasbro — The toymaker tumbled 9.2% following a weaker-than-expected financial report for the third quarter. Hasbro earned $1.64 per share excluding items on $1.5 billion in revenue, while analysts polled by LSEG had anticipated $1.70 per share in earnings and...
Some of the SEC rule proposals generating the most withering criticism are among those that would have the biggest impact on financial advisors. But the widespread opposition won’t necessarily influence the SEC to revise them substantially before they become final regulations. Financial industry trade associations, bipartisan lawmakers on Capitol Hill...
CFOTO | Future Publishing | Getty ImagesPfizer on Thursday said its combination vaccine candidates targeting Covid and the flu will move to a final-stage trial in the coming months after showing positive initial results in an early to mid-stage study.That moves the pharmaceutical giant and its German partner BioNTech...
Merck headquarters in Rahway, New Jersey, on Tuesday, April 18, 2023.Christopher Occhicone | Bloomberg | Getty ImagesMerck on Thursday reported third-quarter revenue and adjusted earnings that topped expectations on strong sales of its blockbuster cancer drug Keytruda, HPV vaccine Gardasil and surprisingly, its Covid drug Lagevrio. The pharmaceutical giant also...
Affluent investors have been pouring money into separately managed accounts and turning slightly away from mutual funds, a new consumer research report shows. As of 2022, 22% of U.S. households that invest had SMAs, up from 13% in 2020, according to data published Thursday by Hearts & Wallets. Meanwhile, mutual...
Bristol Myers Squibb on Thursday reported quarterly adjusted earnings that topped expectations and posted revenue in line with estimates, even as sales of the company's popular blood cancer drug Revlimid plummeted due to generic competition. Bristol Myers, one of the world's largest pharmaceutical companies, raked in $10.96 billion in revenue...
